Ivermectin treatment of naturally acquired and experimentally induced Strongyloides stercoralis infections in dogs

J Am Vet Med Assoc. 1992 Sep 1;201(5):726-30.

Abstract

Treatment of Strongyloides stercoralis infection was investigated in 2 dogs with naturally acquired, chronic-active infections, and in 3 dogs with corticosteroid-enhanced, experimentally induced hyperinfections. A single oral dose of ivermectin was given to naturally infected (200 micrograms/kg of body weight) and experimentally infected (800 micrograms/kg) dogs. Five dogs with experimental hyperinfections served as controls. Dogs with naturally acquired infections ceased to shed first-stage larvae in the feces 1 week after treatment, but 1 dog had recrudescence and required a second dose. Ivermectin was 100% effective in removing adult S stercoralis from the intestinal tract of the experimentally infected dogs, but it was not effective in removing third-stage larvae from parenteral sites. Ivermectin-treated dogs had few intestinal parasites of any stage, whereas at necropsy, 4 of 5 experimentally infected dogs not treated had massive infections (greater than 100,000 adults, greater than 92,000 larvae) in the intestinal tract, and 3 of 5 had larvae (greater than 2,500) in parenteral sites.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Animals
  • Chronic Disease
  • Dog Diseases / drug therapy*
  • Dog Diseases / parasitology
  • Dogs
  • Feces / parasitology
  • Female
  • Intestinal Diseases, Parasitic / drug therapy
  • Intestinal Diseases, Parasitic / parasitology
  • Intestinal Diseases, Parasitic / veterinary*
  • Intestines / parasitology
  • Ivermectin / administration & dosage
  • Ivermectin / therapeutic use*
  • Larva
  • Male
  • Skin / parasitology
  • Strongyloides stercoralis / drug effects*
  • Strongyloides stercoralis / isolation & purification
  • Strongyloidiasis / drug therapy
  • Strongyloidiasis / parasitology
  • Strongyloidiasis / veterinary*

Substances

  • Ivermectin